<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39319267</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-0042</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>iScience</Title><ISOAbbreviation>iScience</ISOAbbreviation></Journal><ArticleTitle>Association of inflammatory cytokines with lung function, chronic lung diseases, and COVID-19.</ArticleTitle><Pagination><StartPage>110704</StartPage><MedlinePgn>110704</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">110704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.isci.2024.110704</ELocationID><Abstract><AbstractText>We investigated the effects of 35 inflammatory cytokines on respiratory outcomes, including COVID-19, asthma (atopic and non-atopic), chronic obstructive pulmonary disease (COPD), and pulmonary function indices, using Mendelian randomization and colocalization analyses. The emerging associations were further explored using observational analyses in the UK Biobank. We found an inverse association between genetically predicted macrophage colony stimulating factor (MCSF), soluble intercellular adhesion molecule-1 (sICAM), and soluble vascular cell adhesion molecule-1 with risk of COVID-19 outcomes. sICAM was positively associated with atopic asthma risk, whereas tumor necrosis factor-alfa showed an inverse association. A positive association was shown between interleukin-18 and COPD risk (replicated in observational analysis), whereas an inverse association was shown for interleukin-1 receptor antagonist (IL-1ra). IL-1ra and monocyte chemotactic protein-3 were positively associated with lung function indices, whereas inverse associations were shown for MCSF and interleukin-18 (replicated in observational analysis). Our results point to these cytokines as potential pharmacological targets for respiratory traits.</AbstractText><CopyrightInformation>© 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rontogianni</LastName><ForeName>Marina O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Dipender</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouras</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asimakopoulos</LastName><ForeName>Alexandros-Georgios</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzoulaki</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karhunen</LastName><ForeName>Ville</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Mathematical Sciences, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtimäki</LastName><ForeName>Terho</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Faculty of Medicine &amp; Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Finnish Cardiovascular Research Center Tampere, Faculty of Medicine &amp; Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raitakari</LastName><ForeName>Olli</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wielscher</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomaa</LastName><ForeName>Veikko</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Finnish Institute for Health and Welfare, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jalkanen</LastName><ForeName>Sirpa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MediCity Research Laboratory, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>InFLAMES Fiagship, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmi</LastName><ForeName>Marko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MediCity Research Laboratory, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>InFLAMES Fiagship, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timonen</LastName><ForeName>Markku</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Unit of Population Health, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Center (MRC) and University Hospital, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yarmolinsky</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobin</LastName><ForeName>Martin D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research, Leicester Respiratory Biomedical Research Centre, Glenfield Hospital, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Abril G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herzig</LastName><ForeName>Karl-Heinz</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Medical Research Center (MRC) and University Hospital, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Biomedicine and Internal Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Gastroenterology and Metabolic Diseases, Pediatric Institute, Poznan University of Medical Sciences, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioannides</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Primary Care and Public Health, School of Public Health, Imperial College London, White City Campus, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarvelin</LastName><ForeName>Marjo-Riitta</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Primary Care, Oulu University Hospital, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehghan</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute at Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsilidis</LastName><ForeName>Konstantinos K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>iScience</MedlineTA><NlmUniqueID>101724038</NlmUniqueID><ISSNLinking>2589-0042</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Association analysis</Keyword><Keyword MajorTopicYN="N">Disease</Keyword><Keyword MajorTopicYN="N">Health sciences</Keyword><Keyword MajorTopicYN="N">Respiratory medicine</Keyword></KeywordList><CoiStatement>The authors declare the following competing interests: Salomaa Veikko was funded by the Finnish Foundation for Cardiovascular Research and by the Juho Vainio Foundation. Salomaa Veikko has received an honorarium from Sanofi for consulting and has ongoing research collaboration with Bayer Ltd. (All outside the present study). These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the article. Sirpa Jalkanen, Marko Salmi: Financial support for cytokine analyses has come from the Finnish Academy. Abril Izquierdo and Martin Tobin were supported for the present article by Wellcome Trust grants (WT202849/Z/16/Z, WT225221/Z/22/Z) and the National Institute of Health and Care Research (NIHR) Leicester Biomedical Research Center. Martin Tobin has also received an NIHR Senior Investigator Award and had a funded research collaboration with Orion Pharma (the latter outside the scope of this work). Markku Timonen has received payment for one lecture for Otsuka Pharmaceutical and payment for two lectures for H. Lundbeck A/S. Marjo-Ritta Jarvelin is partly funded by the Medical Research Council (MR/S019669/1). James Yarmolinsky is supported by a Cancer Research UK Population Research Postdoctoral Fellowship (C68933/A28534). The remaining authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319267</ArticleId><ArticleId IdType="pmc">PMC11417323</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2024.110704</ArticleId><ArticleId IdType="pii">S2589-0042(24)01929-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32279-7</ArticleId><ArticleId IdType="pmc">PMC6227754</ArticleId><ArticleId IdType="pubmed">30496104</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD Chronic Respiratory Disease Collaborators Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 2020;8:585–596. doi: 10.1016/S2213-2600(20)30105-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30105-3</ArticleId><ArticleId IdType="pmc">PMC7284317</ArticleId><ArticleId IdType="pubmed">32526187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R., Hawthorne V.M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996;313:711–716. doi: 10.1136/bmj.313.7059.711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.313.7059.711</ArticleId><ArticleId IdType="pmc">PMC2352103</ArticleId><ArticleId IdType="pubmed">8819439</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Excess Mortality Collaborators Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet (London, England) 2022;399:1513–1536. doi: 10.1016/S0140-6736(21)02796-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255–2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghasafari P., George U., Pidaparti R. A review of inflammatory mechanism in airway diseases. Inflamm. Res. 2019;68:59–74. doi: 10.1007/s00011-018-1191-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-018-1191-2</ArticleId><ArticleId IdType="pubmed">30306206</ArticleId></ArticleIdList></Reference><Reference><Citation>RoActemra | European Medicines Agency [Internet]. https://www.ema.europa.eu/en/medicines/human/EPAR/roactemra.</Citation></Reference><Reference><Citation>Moore T.J., Zhang H., Anderson G., Alexander G.C. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016. JAMA Intern. Med. 2018;178:1451–1457. doi: 10.1001/jamainternmed.2018.3931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2018.3931</ArticleId><ArticleId IdType="pmc">PMC6248200</ArticleId><ArticleId IdType="pubmed">30264133</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Butterworth A., Malarstig A., Thompson S.G. Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ. 2012;345 doi: 10.1136/bmj.e7325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7325</ArticleId><ArticleId IdType="pubmed">23131671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill D., Georgakis M.K., Walker V.M., Schmidt A.F., Gkatzionis A., Freitag D.F., Finan C., Hingorani A.D., Howson J.M.M., Burgess S., et al. Mendelian randomization for studying the effects of perturbing drug targets. Wellcome Open Res. 2021;6:16. doi: 10.12688/wellcomeopenres.16544.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16544.2</ArticleId><ArticleId IdType="pmc">PMC7903200</ArticleId><ArticleId IdType="pubmed">33644404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuber V., Grinberg N.F., Gill D., Manipur I., Slob E.A.W., Patel A., Wallace C., Burgess S. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am. J. Hum. Genet. 2022;109:767–782. doi: 10.1016/j.ajhg.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC7612737</ArticleId><ArticleId IdType="pubmed">35452592</ArticleId></ArticleIdList></Reference><Reference><Citation>Rontogianni M., Gill D., Bouras E., Asimakopoulos A.G., Tzoulaki I., Karhunen V., Lehtimäki T., Raitakari O., Wielscher M., Salomaa V., et al. Poster presentation in: 11th Annual Meeting of the International Cytokine &amp; Interferon Society; 2023. Association of Inflammatory Cytokines with Lung Function, Chronic Lung Diseases and COVID-19.</Citation></Reference><Reference><Citation>Sliz E., Kalaoja M., Ahola-Olli A., Raitakari O., Perola M., Salomaa V., Lehtimäki T., Karhu T., Viinamäki H., Salmi M., et al. Genome-wide association study identifies seven novel loci associating with circulating cytokines and cell adhesion molecules in Finns. J. Med. Genet. 2019;56:607–616. doi: 10.1136/jmedgenet-2018-105965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2018-105965</ArticleId><ArticleId IdType="pmc">PMC6817708</ArticleId><ArticleId IdType="pubmed">31217265</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkersen L., Gustafsson S., Wang Q., Hansen D.H., Hedman Å.K., Schork A., Page K., Zhernakova D.V., Wu Y., Peters J., et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat. Metab. 2020;2:1135–1148. doi: 10.1038/s42255-020-00287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00287-2</ArticleId><ArticleId IdType="pmc">PMC7611474</ArticleId><ArticleId IdType="pubmed">33067605</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B.B., Maranville J.C., Peters J.E., Stacey D., Staley J.R., Blackshaw J., Burgess S., Jiang T., Paige E., Surendran P., et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73–79. doi: 10.1038/s41586-018-0175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0175-2</ArticleId><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Karhunen V., Gill D., Huang J., Bouras E., Malik R., Ponsford M.J., Ahola-Olli A., Papadopoulou A., Palaniswamy S., Sebert S., et al. The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study. BMJ Med. 2023;2 doi: 10.1136/bmjmed-2022-000157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000157</ArticleId><ArticleId IdType="pmc">PMC9978757</ArticleId><ArticleId IdType="pubmed">36936266</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Oulu. Northern Finland Birth Cohort 1966. http://urn.fi/urn:nbn:fi:att:bc1e5408-980e-4a62-b899-43bec3755243..</Citation></Reference><Reference><Citation>Staley J.R., Blackshaw J., Kamat M.A., Ellis S., Surendran P., Sun B.B., Paul D.S., Freitag D., Burgess S., Danesh J., et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016;32:3207–3209. doi: 10.1093/bioinformatics/btw373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw373</ArticleId><ArticleId IdType="pmc">PMC5048068</ArticleId><ArticleId IdType="pubmed">27318201</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M., Jiang Y., Xia D., Xiong Y., Zheng Q., Chen F., Zou L., Xiao W., Zhu Y. Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients. J. Infect. Dis. 2020;222:894–898. doi: 10.1093/infdis/jiaa349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa349</ArticleId><ArticleId IdType="pmc">PMC7337874</ArticleId><ArticleId IdType="pubmed">32582936</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranova A., Luo J., Fu L., Yao G., Zhang F. Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19. Front. Immunol. 2024;15 doi: 10.3389/fimmu.2024.1352583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1352583</ArticleId><ArticleId IdType="pmc">PMC10917991</ArticleId><ArticleId IdType="pubmed">38455043</ArticleId></ArticleIdList></Reference><Reference><Citation>Blease K., Lukacs N.W., Hogaboam C.M., Kunkel S.L. Chemokines and their role in airway hyper-reactivity. Respir. Res. 2000;1:54–61. doi: 10.1186/rr13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/rr13</ArticleId><ArticleId IdType="pmc">PMC59544</ArticleId><ArticleId IdType="pubmed">11667966</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaoka H., Hoshino T., Takei S., Kinoshita T., Okamoto M., Kawayama T., Kato S., Iwasaki H., Watanabe K., Aizawa H. Interleukin-18 production and pulmonary function in COPD. Eur. Respir. J. 2008;31:287–297. doi: 10.1183/09031936.00019207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00019207</ArticleId><ArticleId IdType="pubmed">17989120</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Li R., Piao T.H., Wang C.L., Wu X.L., Cai H.Y. Pathological Mechanism and Targeted Drugs of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2022;17:1565–1575. doi: 10.2147/COPD.S366126.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S366126</ArticleId><ArticleId IdType="pmc">PMC9288175</ArticleId><ArticleId IdType="pubmed">35855746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M.J., Homer R.J., Gallo A., Lee C.G., Crothers K.A., Cho S.J., Rochester C., Cain H., Chupp G., Yoon H.J., Elias J.A. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J. Immunol. 2007;178:1948–1959. doi: 10.4049/jimmunol.178.3.1948.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.3.1948</ArticleId><ArticleId IdType="pubmed">17237446</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranova A., Cao H., Chen J., Zhang F. Causal Association and Shared Genetics Between Asthma and COVID-19. Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.705379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.705379</ArticleId><ArticleId IdType="pmc">PMC8977836</ArticleId><ArticleId IdType="pubmed">35386719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor D.A., Tilling K., Davey Smith G. Triangulation in aetiological epidemiology. Int. J. Epidemiol. 2016;45:1866–1886. doi: 10.1093/ije/dyw314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw314</ArticleId><ArticleId IdType="pmc">PMC5841843</ArticleId><ArticleId IdType="pubmed">28108528</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova V.W., Richmond R.C., Woolf B.A.R., Yarmolinsky J., Davies N.M., Swanson S.A., VanderWeele T.J., Higgins J.P.T., Timpson N.J., Dimou N., et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326:1614–1621. doi: 10.1001/jama.2021.18236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18236</ArticleId><ArticleId IdType="pubmed">34698778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Guo Y., Shi H., Liu C.L., Panganiban R.A., Chung W., O'Connor L.J., Himes B.E., Gazal S., Hasegawa K., et al. Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank. J. Allergy Clin. Immunol. 2020;145:537–549. doi: 10.1016/j.jaci.2019.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.09.035</ArticleId><ArticleId IdType="pmc">PMC7010560</ArticleId><ArticleId IdType="pubmed">31669095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakornsakolpat P., Prokopenko D., Lamontagne M., Reeve N.F., Guyatt A.L., Jackson V.E., Shrine N., Qiao D., Bartz T.M., Kim D.K., et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat. Genet. 2019;51:494–505. doi: 10.1038/s41588-018-0342-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0342-2</ArticleId><ArticleId IdType="pmc">PMC6546635</ArticleId><ArticleId IdType="pubmed">30804561</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrine N., Guyatt A.L., Erzurumluoglu A.M., Jackson V.E., Hobbs B.D., Melbourne C.A., Batini C., Fawcett K.A., Song K., Sakornsakolpat P., et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat. Genet. 2019;51:481–493. doi: 10.1038/s41588-018-0321-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0321-7</ArticleId><ArticleId IdType="pmc">PMC6397078</ArticleId><ArticleId IdType="pubmed">30804560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouras E., Karhunen V., Gill D., Huang J., Haycock P.C., Gunter M.J., Johansson M., Brennan P., Key T., Lewis S.J., et al. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022;20:3. doi: 10.1186/s12916-021-02193-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02193-0</ArticleId><ArticleId IdType="pmc">PMC8750876</ArticleId><ArticleId IdType="pubmed">35012533</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A.F., Finan C., Gordillo-Marañón M., Asselbergs F.W., Freitag D.F., Patel R.S., Tyl B., Chopade S., Faraway R., Zwierzyna M., Hingorani A.D. Genetic drug target validation using Mendelian randomisation. Nat. Commun. 2020;11:3255. doi: 10.1038/s41467-020-16969-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16969-0</ArticleId><ArticleId IdType="pmc">PMC7320010</ArticleId><ArticleId IdType="pubmed">32591531</ArticleId></ArticleIdList></Reference><Reference><Citation>GTEx Consortium The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science (New York, N.Y.) 2020;369:1318–1330. doi: 10.1126/science.aaz1776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz1776</ArticleId><ArticleId IdType="pmc">PMC7737656</ArticleId><ArticleId IdType="pubmed">32913098</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkatzionis A., Burgess S., Newcombe P.J. Statistical methods for cis-Mendelian randomization with two-sample summary-level data. Genet. Epidemiol. 2023;47:3–25. doi: 10.1002/gepi.22506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.22506</ArticleId><ArticleId IdType="pmc">PMC7614127</ArticleId><ArticleId IdType="pubmed">36273411</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Butterworth A., Thompson S.G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 2013;37:658–665. doi: 10.1002/gepi.21758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21758</ArticleId><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. Roy. Stat. Soc. B. 1995;57:289–300. http://www.jstor.org/stable/2346101</Citation></Reference><Reference><Citation>Palmer T.M., Lawlor D.A., Harbord R.M., Sheehan N.A., Tobias J.H., Timpson N.J., Davey Smith G., Sterne J.A.C. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat. Methods Med. Res. 2012;21:223–242. doi: 10.1177/0962280210394459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280210394459</ArticleId><ArticleId IdType="pmc">PMC3917707</ArticleId><ArticleId IdType="pubmed">21216802</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion M.J.A., Shakhbazov K., Visscher P.M. Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol. 2013;42:1497–1501. doi: 10.1093/ije/dyt179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt179</ArticleId><ArticleId IdType="pmc">PMC3807619</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Davey Smith G., Haycock P.C., Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet. Epidemiol. 2016;40:304–314. doi: 10.1002/gepi.21965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Davey Smith G., Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 2015;44:512–525. doi: 10.1093/ije/dyv080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M., Chen C.Y., Neale B., Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 2018;50:693–698. doi: 10.1038/s41588-018-0099-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduri C., Bock C., Gundersen S., Hovig E., Sandve G.K. Colocalization analyses of genomic elements: approaches, recommendations and challenges. Bioinformatics. 2019;35:1615–1624. doi: 10.1093/bioinformatics/bty835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty835</ArticleId><ArticleId IdType="pmc">PMC6499241</ArticleId><ArticleId IdType="pubmed">30307532</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Biobank - UK Biobank. https://www.ukbiobank.ac.uk/.</Citation></Reference><Reference><Citation>Sun B.B., Chiou J., Traylor M., Benner C., Hsu Y.H., Richardson T.G., Surendran P., Mahajan A., Robins C., Vasquez-Grinnell S.G., et al. Genetic Regulation of the Human Plasma Proteome in 54,306 UK Biobank Participants. bioRxiv. 2022 doi: 10.1101/2022.06.17.496443. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.17.496443</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team. R: A language and environment for statistical computing. https://www.r-project.org.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>